% IMPORTANT: The following is UTF-8 encoded. This means that in the presence
% of non-ASCII characters, it will not work with BibTeX 0.99 or older.
% Instead, you should use an up-to-date BibTeX implementation like “bibtex8” or
% “biber”.
@ARTICLE{Galldiks:862734,
author = {Galldiks, Norbert and Unterrainer, Marcus and Judov,
Natalie and Stoffels, Gabriele and Rapp, Marion and Lohmann,
Philipp and Vettermann, Franziska and Dunkl, Veronika and
Suchorska, Bogdana and Tonn, Jörg C and Kreth,
Friedrich-Wilhem and Fink, Gereon Rudolf and Bartenstein,
Peter and Langen, Karl-Josef and Albert, Nathalie L},
title = {{P}hotopenic defects on
{O}-(2-[18{F}]-fluoroethyl)-{L}-tyrosine {PET} - {C}linical
relevance in glioma patients},
journal = {Neuro-Oncology},
volume = {21},
number = {10},
issn = {1523-5866},
address = {Oxford},
publisher = {Oxford Univ. Press},
reportid = {FZJ-2019-02976},
pages = {1331-1338},
year = {2019},
abstract = {BackgroundO-(2-[18F]-fluoroethyl)-L-tyrosine (FET) PET has
a sensitivity of more than $90\%$ to detect gliomas. In the
remaining small fraction of gliomas without increased tracer
uptake, some tumors even show photopenic defects whose
clinical significance is unclear.MethodsGlioma patients with
a negative FET PET scan prior to neuropathological
confirmation were identified retrospectively. Gliomas were
rated visually as (i) having indifferent FET uptake or (ii)
photopenic, if FET uptake was below background activity. FET
uptake in the area of signal hyperintensity on the T2/fluid
attenuated inversion recovery–weighted MRI was evaluated
by mean standardized uptake value (SUV) and mean
tumor-to-brain ratio (TBR). The progression-free survival
(PFS) of photopenic gliomas was compared with that of
gliomas with indifferent FET uptake.ResultsOf 100
FET-negative gliomas, 40 cases with photopenic defects were
identified. Fifteen of these 40 cases $(38\%)$ had World
Health Organization (WHO) grades III and IV gliomas. FET
uptake in photopenic gliomas was significantly decreased
compared with both the healthy-appearing brain tissue (SUV,
0.89 ± 0.26 vs 1.08 ± 0.23; P < 0.001) and gliomas with
indifferent FET uptake (TBR, 0.82 ± 0.09 vs 0.96 ± 0.13; P
< 0.001). Irrespective of the applied treatment, isocitrate
dehydrogenase (IDH)–mutated WHO grade II diffuse
astrocytoma patients with indifferent FET uptake (n = 25)
had a significantly longer PFS than patients with
IDH-mutated diffuse astrocytomas (WHO grade II) with
photopenic defects (n = 11) (51 vs 24 mo; P = 0.027). The
multivariate survival analysis indicated that photopenic
defects predict an unfavorable PFS (P =
0.009).ConclusionPhotopenic gliomas in negative FET PET
scans should be managed more actively, as they seem to have
a higher risk of harboring a higher-grade glioma and an
unfavorable outcome.},
cin = {INM-3 / INM-4},
ddc = {610},
cid = {I:(DE-Juel1)INM-3-20090406 / I:(DE-Juel1)INM-4-20090406},
pnm = {572 - (Dys-)function and Plasticity (POF3-572)},
pid = {G:(DE-HGF)POF3-572},
typ = {PUB:(DE-HGF)16},
pubmed = {pmid:31077276},
UT = {WOS:000493086800015},
doi = {10.1093/neuonc/noz083},
url = {https://juser.fz-juelich.de/record/862734},
}